CRISPR & Cas9 - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes.  Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.

The global market for CRISPR & Cas9 was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for CRISPR & Cas9 was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for CRISPR & Cas9 was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for CRISPR & Cas9 was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of CRISPR & Cas9 include Caribou Biosciences, Integrated DNA Technologies(IDT), CRISPR Therapeutics, Merck, Mirus Bio, Editas Medicine, Takara Bio, Thermo Fisher Scientific and Horizon Discovery Group, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for CRISPR & Cas9, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of CRISPR & Cas9 by region & country, by Type, and by Application.

The CRISPR & Cas9 market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR & Cas9.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of CRISPR & Cas9 manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of CRISPR & Cas9 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of CRISPR & Cas9 in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 CRISPR & Cas9 Product Introduction
    1.2 Global CRISPR & Cas9 Market Size Forecast
    1.3 CRISPR & Cas9 Market Trends & Drivers
        1.3.1 CRISPR & Cas9 Industry Trends
        1.3.2 CRISPR & Cas9 Market Drivers & Opportunity
        1.3.3 CRISPR & Cas9 Market Challenges
        1.3.4 CRISPR & Cas9 Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global CRISPR & Cas9 Players Revenue Ranking (2023)
    2.2 Global CRISPR & Cas9 Revenue by Company (2019-2024)
    2.3 Key Companies CRISPR & Cas9 Manufacturing Base Distribution and Headquarters
    2.4 Key Companies CRISPR & Cas9 Product Offered
    2.5 Key Companies Time to Begin Mass Production of CRISPR & Cas9
    2.6 CRISPR & Cas9 Market Competitive Analysis
        2.6.1 CRISPR & Cas9 Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by CRISPR & Cas9 Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR & Cas9 as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Genome Editing
        3.1.2 Genetic Engineering
        3.1.3 gRNA Database/Gene Librar
        3.1.4 CRISPR Plasmid
        3.1.5 Human Stem Cells
        3.1.6 Genetically Modified Organisms/Crops
        3.1.7 Cell Line Engineering
    3.2 Global CRISPR & Cas9 Sales Value by Type
        3.2.1 Global CRISPR & Cas9 Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global CRISPR & Cas9 Sales Value, by Type (2019-2030)
        3.2.3 Global CRISPR & Cas9 Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Biotechnology Companies
        4.1.2 Pharmaceutical Companies
        4.1.3 Academic Institutes
        4.1.4 Research and Development Institutes
    4.2 Global CRISPR & Cas9 Sales Value by Application
        4.2.1 Global CRISPR & Cas9 Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global CRISPR & Cas9 Sales Value, by Application (2019-2030)
        4.2.3 Global CRISPR & Cas9 Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global CRISPR & Cas9 Sales Value by Region
        5.1.1 Global CRISPR & Cas9 Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global CRISPR & Cas9 Sales Value by Region (2019-2024)
        5.1.3 Global CRISPR & Cas9 Sales Value by Region (2025-2030)
        5.1.4 Global CRISPR & Cas9 Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America CRISPR & Cas9 Sales Value, 2019-2030
        5.2.2 North America CRISPR & Cas9 Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe CRISPR & Cas9 Sales Value, 2019-2030
        5.3.2 Europe CRISPR & Cas9 Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific CRISPR & Cas9 Sales Value, 2019-2030
        5.4.2 Asia Pacific CRISPR & Cas9 Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America CRISPR & Cas9 Sales Value, 2019-2030
        5.5.2 South America CRISPR & Cas9 Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa CRISPR & Cas9 Sales Value, 2019-2030
        5.6.2 Middle East & Africa CRISPR & Cas9 Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions CRISPR & Cas9 Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions CRISPR & Cas9 Sales Value
    6.3 United States
        6.3.1 United States CRISPR & Cas9 Sales Value, 2019-2030
        6.3.2 United States CRISPR & Cas9 Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States CRISPR & Cas9 Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe CRISPR & Cas9 Sales Value, 2019-2030
        6.4.2 Europe CRISPR & Cas9 Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe CRISPR & Cas9 Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China CRISPR & Cas9 Sales Value, 2019-2030
        6.5.2 China CRISPR & Cas9 Sales Value by Type (%), 2023 VS 2030
        6.5.3 China CRISPR & Cas9 Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan CRISPR & Cas9 Sales Value, 2019-2030
        6.6.2 Japan CRISPR & Cas9 Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan CRISPR & Cas9 Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea CRISPR & Cas9 Sales Value, 2019-2030
        6.7.2 South Korea CRISPR & Cas9 Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea CRISPR & Cas9 Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia CRISPR & Cas9 Sales Value, 2019-2030
        6.8.2 Southeast Asia CRISPR & Cas9 Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia CRISPR & Cas9 Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India CRISPR & Cas9 Sales Value, 2019-2030
        6.9.2 India CRISPR & Cas9 Sales Value by Type (%), 2023 VS 2030
        6.9.3 India CRISPR & Cas9 Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Caribou Biosciences
        7.1.1 Caribou Biosciences Profile
        7.1.2 Caribou Biosciences Main Business
        7.1.3 Caribou Biosciences CRISPR & Cas9 Products, Services and Solutions
        7.1.4 Caribou Biosciences CRISPR & Cas9 Revenue (US$ Million) & (2019-2024)
        7.1.5 Caribou Biosciences Recent Developments
    7.2 Integrated DNA Technologies(IDT)
        7.2.1 Integrated DNA Technologies(IDT) Profile
        7.2.2 Integrated DNA Technologies(IDT) Main Business
        7.2.3 Integrated DNA Technologies(IDT) CRISPR & Cas9 Products, Services and Solutions
        7.2.4 Integrated DNA Technologies(IDT) CRISPR & Cas9 Revenue (US$ Million) & (2019-2024)
        7.2.5 Integrated DNA Technologies(IDT) Recent Developments
    7.3 CRISPR Therapeutics
        7.3.1 CRISPR Therapeutics Profile
        7.3.2 CRISPR Therapeutics Main Business
        7.3.3 CRISPR Therapeutics CRISPR & Cas9 Products, Services and Solutions
        7.3.4 CRISPR Therapeutics CRISPR & Cas9 Revenue (US$ Million) & (2019-2024)
        7.3.5 Merck Recent Developments
    7.4 Merck
        7.4.1 Merck Profile
        7.4.2 Merck Main Business
        7.4.3 Merck CRISPR & Cas9 Products, Services and Solutions
        7.4.4 Merck CRISPR & Cas9 Revenue (US$ Million) & (2019-2024)
        7.4.5 Merck Recent Developments
    7.5 Mirus Bio
        7.5.1 Mirus Bio Profile
        7.5.2 Mirus Bio Main Business
        7.5.3 Mirus Bio CRISPR & Cas9 Products, Services and Solutions
        7.5.4 Mirus Bio CRISPR & Cas9 Revenue (US$ Million) & (2019-2024)
        7.5.5 Mirus Bio Recent Developments
    7.6 Editas Medicine
        7.6.1 Editas Medicine Profile
        7.6.2 Editas Medicine Main Business
        7.6.3 Editas Medicine CRISPR & Cas9 Products, Services and Solutions
        7.6.4 Editas Medicine CRISPR & Cas9 Revenue (US$ Million) & (2019-2024)
        7.6.5 Editas Medicine Recent Developments
    7.7 Takara Bio
        7.7.1 Takara Bio Profile
        7.7.2 Takara Bio Main Business
        7.7.3 Takara Bio CRISPR & Cas9 Products, Services and Solutions
        7.7.4 Takara Bio CRISPR & Cas9 Revenue (US$ Million) & (2019-2024)
        7.7.5 Takara Bio Recent Developments
    7.8 Thermo Fisher Scientific
        7.8.1 Thermo Fisher Scientific Profile
        7.8.2 Thermo Fisher Scientific Main Business
        7.8.3 Thermo Fisher Scientific CRISPR & Cas9 Products, Services and Solutions
        7.8.4 Thermo Fisher Scientific CRISPR & Cas9 Revenue (US$ Million) & (2019-2024)
        7.8.5 Thermo Fisher Scientific Recent Developments
    7.9 Horizon Discovery Group
        7.9.1 Horizon Discovery Group Profile
        7.9.2 Horizon Discovery Group Main Business
        7.9.3 Horizon Discovery Group CRISPR & Cas9 Products, Services and Solutions
        7.9.4 Horizon Discovery Group CRISPR & Cas9 Revenue (US$ Million) & (2019-2024)
        7.9.5 Horizon Discovery Group Recent Developments
    7.10 Intellia Therapeutics
        7.10.1 Intellia Therapeutics Profile
        7.10.2 Intellia Therapeutics Main Business
        7.10.3 Intellia Therapeutics CRISPR & Cas9 Products, Services and Solutions
        7.10.4 Intellia Therapeutics CRISPR & Cas9 Revenue (US$ Million) & (2019-2024)
        7.10.5 Intellia Therapeutics Recent Developments
    7.11 Agilent Technologies
        7.11.1 Agilent Technologies Profile
        7.11.2 Agilent Technologies Main Business
        7.11.3 Agilent Technologies CRISPR & Cas9 Products, Services and Solutions
        7.11.4 Agilent Technologies CRISPR & Cas9 Revenue (US$ Million) & (2019-2024)
        7.11.5 Agilent Technologies Recent Developments
    7.12 Cellecta
        7.12.1 Cellecta Profile
        7.12.2 Cellecta Main Business
        7.12.3 Cellecta CRISPR & Cas9 Products, Services and Solutions
        7.12.4 Cellecta CRISPR & Cas9 Revenue (US$ Million) & (2019-2024)
        7.12.5 Cellecta Recent Developments
    7.13 GenScript
        7.13.1 GenScript Profile
        7.13.2 GenScript Main Business
        7.13.3 GenScript CRISPR & Cas9 Products, Services and Solutions
        7.13.4 GenScript CRISPR & Cas9 Revenue (US$ Million) & (2019-2024)
        7.13.5 GenScript Recent Developments
    7.14 GeneCopoeia
        7.14.1 GeneCopoeia Profile
        7.14.2 GeneCopoeia Main Business
        7.14.3 GeneCopoeia CRISPR & Cas9 Products, Services and Solutions
        7.14.4 GeneCopoeia CRISPR & Cas9 Revenue (US$ Million) & (2019-2024)
        7.14.5 GeneCopoeia Recent Developments
    7.15 Synthego
        7.15.1 Synthego Profile
        7.15.2 Synthego Main Business
        7.15.3 Synthego CRISPR & Cas9 Products, Services and Solutions
        7.15.4 Synthego CRISPR & Cas9 Revenue (US$ Million) & (2019-2024)
        7.15.5 Synthego Recent Developments

 8 Industry Chain Analysis
    8.1 CRISPR & Cas9 Industrial Chain
    8.2 CRISPR & Cas9 Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 CRISPR & Cas9 Sales Model
        8.5.2 Sales Channel
        8.5.3 CRISPR & Cas9 Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. CRISPR & Cas9 Market Trends
    Table 2. CRISPR & Cas9 Market Drivers & Opportunity
    Table 3. CRISPR & Cas9 Market Challenges
    Table 4. CRISPR & Cas9 Market Restraints
    Table 5. Global CRISPR & Cas9 Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global CRISPR & Cas9 Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies CRISPR & Cas9 Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies CRISPR & Cas9 Product Type
    Table 9. Key Companies Time to Begin Mass Production of CRISPR & Cas9
    Table 10. Global CRISPR & Cas9 Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR & Cas9 as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global CRISPR & Cas9 Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global CRISPR & Cas9 Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global CRISPR & Cas9 Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global CRISPR & Cas9 Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global CRISPR & Cas9 Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global CRISPR & Cas9 Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global CRISPR & Cas9 Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global CRISPR & Cas9 Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global CRISPR & Cas9 Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global CRISPR & Cas9 Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global CRISPR & Cas9 Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global CRISPR & Cas9 Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global CRISPR & Cas9 Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global CRISPR & Cas9 Sales Value by Region (2019-2024) & (%)
    Table 27. Global CRISPR & Cas9 Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions CRISPR & Cas9 Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions CRISPR & Cas9 Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions CRISPR & Cas9 Sales Value, (2025-2030) & (US$ Million)
    Table 31. Caribou Biosciences Basic Information List
    Table 32. Caribou Biosciences Description and Business Overview
    Table 33. Caribou Biosciences CRISPR & Cas9 Products, Services and Solutions
    Table 34. Revenue (US$ Million) in CRISPR & Cas9 Business of Caribou Biosciences (2019-2024)
    Table 35. Caribou Biosciences Recent Developments
    Table 36. Integrated DNA Technologies(IDT) Basic Information List
    Table 37. Integrated DNA Technologies(IDT) Description and Business Overview
    Table 38. Integrated DNA Technologies(IDT) CRISPR & Cas9 Products, Services and Solutions
    Table 39. Revenue (US$ Million) in CRISPR & Cas9 Business of Integrated DNA Technologies(IDT) (2019-2024)
    Table 40. Integrated DNA Technologies(IDT) Recent Developments
    Table 41. CRISPR Therapeutics Basic Information List
    Table 42. CRISPR Therapeutics Description and Business Overview
    Table 43. CRISPR Therapeutics CRISPR & Cas9 Products, Services and Solutions
    Table 44. Revenue (US$ Million) in CRISPR & Cas9 Business of CRISPR Therapeutics (2019-2024)
    Table 45. CRISPR Therapeutics Recent Developments
    Table 46. Merck Basic Information List
    Table 47. Merck Description and Business Overview
    Table 48. Merck CRISPR & Cas9 Products, Services and Solutions
    Table 49. Revenue (US$ Million) in CRISPR & Cas9 Business of Merck (2019-2024)
    Table 50. Merck Recent Developments
    Table 51. Mirus Bio Basic Information List
    Table 52. Mirus Bio Description and Business Overview
    Table 53. Mirus Bio CRISPR & Cas9 Products, Services and Solutions
    Table 54. Revenue (US$ Million) in CRISPR & Cas9 Business of Mirus Bio (2019-2024)
    Table 55. Mirus Bio Recent Developments
    Table 56. Editas Medicine Basic Information List
    Table 57. Editas Medicine Description and Business Overview
    Table 58. Editas Medicine CRISPR & Cas9 Products, Services and Solutions
    Table 59. Revenue (US$ Million) in CRISPR & Cas9 Business of Editas Medicine (2019-2024)
    Table 60. Editas Medicine Recent Developments
    Table 61. Takara Bio Basic Information List
    Table 62. Takara Bio Description and Business Overview
    Table 63. Takara Bio CRISPR & Cas9 Products, Services and Solutions
    Table 64. Revenue (US$ Million) in CRISPR & Cas9 Business of Takara Bio (2019-2024)
    Table 65. Takara Bio Recent Developments
    Table 66. Thermo Fisher Scientific Basic Information List
    Table 67. Thermo Fisher Scientific Description and Business Overview
    Table 68. Thermo Fisher Scientific CRISPR & Cas9 Products, Services and Solutions
    Table 69. Revenue (US$ Million) in CRISPR & Cas9 Business of Thermo Fisher Scientific (2019-2024)
    Table 70. Thermo Fisher Scientific Recent Developments
    Table 71. Horizon Discovery Group Basic Information List
    Table 72. Horizon Discovery Group Description and Business Overview
    Table 73. Horizon Discovery Group CRISPR & Cas9 Products, Services and Solutions
    Table 74. Revenue (US$ Million) in CRISPR & Cas9 Business of Horizon Discovery Group (2019-2024)
    Table 75. Horizon Discovery Group Recent Developments
    Table 76. Intellia Therapeutics Basic Information List
    Table 77. Intellia Therapeutics Description and Business Overview
    Table 78. Intellia Therapeutics CRISPR & Cas9 Products, Services and Solutions
    Table 79. Revenue (US$ Million) in CRISPR & Cas9 Business of Intellia Therapeutics (2019-2024)
    Table 80. Intellia Therapeutics Recent Developments
    Table 81. Agilent Technologies Basic Information List
    Table 82. Agilent Technologies Description and Business Overview
    Table 83. Agilent Technologies CRISPR & Cas9 Products, Services and Solutions
    Table 84. Revenue (US$ Million) in CRISPR & Cas9 Business of Agilent Technologies (2019-2024)
    Table 85. Agilent Technologies Recent Developments
    Table 86. Cellecta Basic Information List
    Table 87. Cellecta Description and Business Overview
    Table 88. Cellecta CRISPR & Cas9 Products, Services and Solutions
    Table 89. Revenue (US$ Million) in CRISPR & Cas9 Business of Cellecta (2019-2024)
    Table 90. Cellecta Recent Developments
    Table 91. GenScript Basic Information List
    Table 92. GenScript Description and Business Overview
    Table 93. GenScript CRISPR & Cas9 Products, Services and Solutions
    Table 94. Revenue (US$ Million) in CRISPR & Cas9 Business of GenScript (2019-2024)
    Table 95. GenScript Recent Developments
    Table 96. GeneCopoeia Basic Information List
    Table 97. GeneCopoeia Description and Business Overview
    Table 98. GeneCopoeia CRISPR & Cas9 Products, Services and Solutions
    Table 99. Revenue (US$ Million) in CRISPR & Cas9 Business of GeneCopoeia (2019-2024)
    Table 100. GeneCopoeia Recent Developments
    Table 101. Synthego Basic Information List
    Table 102. Synthego Description and Business Overview
    Table 103. Synthego CRISPR & Cas9 Products, Services and Solutions
    Table 104. Revenue (US$ Million) in CRISPR & Cas9 Business of Synthego (2019-2024)
    Table 105. Synthego Recent Developments
    Table 106. Key Raw Materials Lists
    Table 107. Raw Materials Key Suppliers Lists
    Table 108. CRISPR & Cas9 Downstream Customers
    Table 109. CRISPR & Cas9 Distributors List
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
    Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. CRISPR & Cas9 Product Picture
    Figure 2. Global CRISPR & Cas9 Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global CRISPR & Cas9 Sales Value (2019-2030) & (US$ Million)
    Figure 4. CRISPR & Cas9 Report Years Considered
    Figure 5. Global CRISPR & Cas9 Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by CRISPR & Cas9 Revenue in 2023
    Figure 7. CRISPR & Cas9 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Genome Editing Picture
    Figure 9. Genetic Engineering Picture
    Figure 10. gRNA Database/Gene Librar Picture
    Figure 11. CRISPR Plasmid Picture
    Figure 12. Human Stem Cells Picture
    Figure 13. Genetically Modified Organisms/Crops Picture
    Figure 14. Cell Line Engineering Picture
    Figure 15. Global CRISPR & Cas9 Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global CRISPR & Cas9 Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Product Picture of Biotechnology Companies
    Figure 18. Product Picture of Pharmaceutical Companies
    Figure 19. Product Picture of Academic Institutes
    Figure 20. Product Picture of Research and Development Institutes
    Figure 21. Global CRISPR & Cas9 Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global CRISPR & Cas9 Sales Value Market Share by Application, 2023 & 2030
    Figure 23. North America CRISPR & Cas9 Sales Value (2019-2030) & (US$ Million)
    Figure 24. North America CRISPR & Cas9 Sales Value by Country (%), 2023 VS 2030
    Figure 25. Europe CRISPR & Cas9 Sales Value (2019-2030) & (US$ Million)
    Figure 26. Europe CRISPR & Cas9 Sales Value by Country (%), 2023 VS 2030
    Figure 27. Asia Pacific CRISPR & Cas9 Sales Value (2019-2030) & (US$ Million)
    Figure 28. Asia Pacific CRISPR & Cas9 Sales Value by Country (%), 2023 VS 2030
    Figure 29. South America CRISPR & Cas9 Sales Value (2019-2030) & (US$ Million)
    Figure 30. South America CRISPR & Cas9 Sales Value by Country (%), 2023 VS 2030
    Figure 31. Middle East & Africa CRISPR & Cas9 Sales Value (2019-2030) & (US$ Million)
    Figure 32. Middle East & Africa CRISPR & Cas9 Sales Value by Country (%), 2023 VS 2030
    Figure 33. Key Countries/Regions CRISPR & Cas9 Sales Value (%), (2019-2030)
    Figure 34. United States CRISPR & Cas9 Sales Value, (2019-2030) & (US$ Million)
    Figure 35. United States CRISPR & Cas9 Sales Value by Type (%), 2023 VS 2030
    Figure 36. United States CRISPR & Cas9 Sales Value by Application (%), 2023 VS 2030
    Figure 37. Europe CRISPR & Cas9 Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Europe CRISPR & Cas9 Sales Value by Type (%), 2023 VS 2030
    Figure 39. Europe CRISPR & Cas9 Sales Value by Application (%), 2023 VS 2030
    Figure 40. China CRISPR & Cas9 Sales Value, (2019-2030) & (US$ Million)
    Figure 41. China CRISPR & Cas9 Sales Value by Type (%), 2023 VS 2030
    Figure 42. China CRISPR & Cas9 Sales Value by Application (%), 2023 VS 2030
    Figure 43. Japan CRISPR & Cas9 Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Japan CRISPR & Cas9 Sales Value by Type (%), 2023 VS 2030
    Figure 45. Japan CRISPR & Cas9 Sales Value by Application (%), 2023 VS 2030
    Figure 46. South Korea CRISPR & Cas9 Sales Value, (2019-2030) & (US$ Million)
    Figure 47. South Korea CRISPR & Cas9 Sales Value by Type (%), 2023 VS 2030
    Figure 48. South Korea CRISPR & Cas9 Sales Value by Application (%), 2023 VS 2030
    Figure 49. Southeast Asia CRISPR & Cas9 Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Southeast Asia CRISPR & Cas9 Sales Value by Type (%), 2023 VS 2030
    Figure 51. Southeast Asia CRISPR & Cas9 Sales Value by Application (%), 2023 VS 2030
    Figure 52. India CRISPR & Cas9 Sales Value, (2019-2030) & (US$ Million)
    Figure 53. India CRISPR & Cas9 Sales Value by Type (%), 2023 VS 2030
    Figure 54. India CRISPR & Cas9 Sales Value by Application (%), 2023 VS 2030
    Figure 55. CRISPR & Cas9 Industrial Chain
    Figure 56. CRISPR & Cas9 Manufacturing Cost Structure
    Figure 57. Channels of Distribution (Direct Sales, and Distribution)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation

CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes.  Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.

The global market for CRISPR & Cas9 was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for CRISPR & Cas9 was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for CRISPR & Cas9 was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for CRISPR & Cas9 was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of CRISPR & Cas9 include Caribou Biosciences, Integrated DNA Technologies(IDT), CRISPR Therapeutics, Merck, Mirus Bio, Editas Medicine, Takara Bio, Thermo Fisher Scientific and Horizon Discovery Group, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for CRISPR & Cas9, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of CRISPR & Cas9 by region & country, by Type, and by Application.

The CRISPR & Cas9 market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR & Cas9.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of CRISPR & Cas9 manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of CRISPR & Cas9 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of CRISPR & Cas9 in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.